UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
70 hedge funds and large institutions have $14.2M invested in Unity Biotechnology in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
34% less capital invested
Capital invested by funds: $21.3M → $14.2M (-$7.19M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
70
Holding in Top 10
1
Calls
$1.98M
Puts
$130K
Top Buyers
| 1 | +$1.77M | |
| 2 | +$252K | |
| 3 | +$224K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$124K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$82.6K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$1.08M | |
| 3 | -$732K | |
| 4 |
Two Sigma Investments
New York
|
-$428K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$240K |